Literature DB >> 18463429

Effect of micronutrient supplementation on mood in nursing home residents.

M A Gosney1, M F Hammond, A Shenkin, S Allsup.   

Abstract

One third of older people in nursing and/or residential homes have significant symptoms of depression. In younger people, deficiencies in selenium, vitamin C and folate are associated with depression. This study examines the association between micronutrient status and mood before and after supplementation. The objective was to determine whether the administration of selenium, vitamin C and folate improved mood in frail elderly nursing home residents. Mood was assessed using the Hospital Anxiety and Depression rating scale (HAD), and Montgomery-Asberg Depression Rating Scale (MADRS). Micronutrient supplementation was provided for 8 weeks in a double-blinded randomised controlled trial. Significant symptoms of depression (29%) and anxiety (24%) were found at baseline. 67% of patients had low serum concentrations of vitamin C, but no-one was below the reference range for selenium. Depression was significantly associated with selenium levels, but not with folate or vitamin C levels. No individual with a HAD depression score of >or=8, had selenium levels >1.2 microM. In those patients with higher HAD depression scores, there was a significant reduction in the score and a significant increase in serum selenium levels after 8 weeks of micronutrient supplementation. Placebo group scores were unchanged. This small study concluded that depression was associated with low levels of selenium in frail older individuals. Following 8 weeks of micronutrient supplementation, there was a significant increase in selenium levels and improved symptoms of depression occurred in a subgroup. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463429     DOI: 10.1159/000131886

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  16 in total

1.  Selenium exposure and depressive symptoms: the Coronary Artery Risk Development in Young Adults Trace Element Study.

Authors:  Laura A Colangelo; Ka He; Mary A Whooley; Martha L Daviglus; Steven Morris; Kiang Liu
Journal:  Neurotoxicology       Date:  2014-02-20       Impact factor: 4.398

2.  Sex-specific transcriptional responses of the zebrafish (Danio rerio) brain selenoproteome to acute sodium selenite supplementation.

Authors:  Maia J Benner; Matt L Settles; Gordon K Murdoch; Ronald W Hardy; Barrie D Robison
Journal:  Physiol Genomics       Date:  2013-06-04       Impact factor: 3.107

Review 3.  Dietary and botanical anxiolytics.

Authors:  Elham Alramadhan; Mirna S Hanna; Mena S Hanna; Todd A Goldstein; Samantha M Avila; Benjamin S Weeks
Journal:  Med Sci Monit       Date:  2012-04

4.  Selenium level and depressive symptoms in a rural elderly Chinese cohort.

Authors:  Sujuan Gao; Yinlong Jin; Frederick W Unverzagt; Chaoke Liang; Kathleen S Hall; Jingxiang Cao; Feng Ma; Jill R Murrell; Yibin Cheng; Ping Li; Jianchao Bian; Hugh C Hendrie
Journal:  BMC Psychiatry       Date:  2012-07-03       Impact factor: 3.630

Review 5.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

6.  Oxidant balance in brain of rats receiving different compounds of selenium.

Authors:  Irena Musik; Małgorzata Kiełczykowska; Joanna Kocot
Journal:  Biometals       Date:  2013-07-10       Impact factor: 2.949

7.  Vitamin C as an adjuvant for treating major depressive disorder and suicidal behavior, a randomized placebo-controlled clinical trial.

Authors:  Ali Sahraian; Ahmad Ghanizadeh; Fereshteh Kazemeini
Journal:  Trials       Date:  2015-03-14       Impact factor: 2.279

8.  Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.

Authors:  Mostafa Amr; Ahmed El-Mogy; Tarek Shams; Karen Vieira; Shaheen E Lakhan
Journal:  Nutr J       Date:  2013-03-09       Impact factor: 3.271

9.  Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.

Authors:  J Sarris; S Moylan; D A Camfield; M P Pase; D Mischoulon; M Berk; F N Jacka; I Schweitzer
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-27       Impact factor: 2.629

10.  The impact of GPX1 on the association of groundwater selenium and depression: a Project FRONTIER study.

Authors:  Leigh A Johnson; Jack A Phillips; Cortney Mauer; Melissa Edwards; Valerie Hobson Balldin; James R Hall; Robert Barber; Tori L Conger; Eric J Ho; Sid E O'Bryant
Journal:  BMC Psychiatry       Date:  2013-01-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.